In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Daphne Zohar, Founder and CEO of PureTech. Daphne sheds light on how their unique and innovative business model looks to solve unmet needs and problem areas across the industry, how they differ from your typical biotech and the benefit of their problem centric approach. She explores how they’re constantly innovating their internal pipeline and adapting to the needs of the market, such as using LYT-100, an existing program, to treat post-recovery complications from COVID-19. Daphne also shares her excitement at how the industry is becoming more open to new ideas and new models for developing medicines.  Hosted on Acast. See acast.com/privacy for more information.